Part A 22 , 621632 (2016)
BPC 157 and Standard Angiogenic Growth Factors Key Findings: BPC-157, when compared to standard peptidergic angiogenic growth factors (EGF, FGF, VEGF), has been effective in all models of acute/chronic injury of the gastrointestinal tract, whether administered intraperitoneally, per-orally, or locally
The neurocognitive effects of repeated acute BDNF doses via RT requires further research, as much of the current evidence aside from the work conducted by Church et al suggests that RT does not increase basal blood BDNF levels
9.4 Probiotics in GI disorders Probiotics hold considerable promise as therapeutic agents for a spectrum of medical conditions, encompassing lactose intolerance, GI and urogenital infections, ulcerative colitis, neoplasms of the digestive tract, and Crohns disease, as shown in Table 3